Comparison of the Genetic Alterations between Primary Colorectal Cancers and Their Corresponding Patient-Derived Xenograft Tissues
Patient-derived xenograft (PDX) models are useful tools for tumor biology research and testing the efficacy of candidate anticancer drugs targeting the druggable mutations identified in tumor tissue. However, it is still unknown how much of the genetic alterations identified in primary tumors are co...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioMed Central
2018-06-01
|
| Series: | Genomics & Informatics |
| Subjects: | |
| Online Access: | http://genominfo.org/upload/pdf/gi-2018-16-2-30.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832573724212068352 |
|---|---|
| author | Sang Mi Yu Seung-Hyun Jung Yeun-Jun Chung |
| author_facet | Sang Mi Yu Seung-Hyun Jung Yeun-Jun Chung |
| author_sort | Sang Mi Yu |
| collection | DOAJ |
| description | Patient-derived xenograft (PDX) models are useful tools for tumor biology research and testing the efficacy of candidate anticancer drugs targeting the druggable mutations identified in tumor tissue. However, it is still unknown how much of the genetic alterations identified in primary tumors are consistently detected in tumor tissues in the PDX model. In this study, we analyzed the genetic alterations of three primary colorectal cancers (CRCs) and matched xenograft tissues in PDX models using a next-generation sequencing cancer panel. Of the 17 somatic mutations identified from the three CRCs, 14 (82.4%) were consistently identified in both primary and xenograft tumors. The other three mutations identified in the primary tumor were not detected in the xenograft tumor tissue. There was no newly identified mutation in the xenograft tumor tissues. In addition to the somatic mutations, the copy number alteration profiles were also largely consistent between the primary tumor and xenograft tissue. All of these data suggest that the PDX tumor model preserves the majority of the key mutations detected in the primary tumor site. This study provides evidence that the PDX model is useful for testing targeted therapies in the clinical field and research on precision medicine. |
| format | Article |
| id | doaj-art-d8fb9bfdf4404df0898f8abc86882abf |
| institution | Kabale University |
| issn | 2234-0742 |
| language | English |
| publishDate | 2018-06-01 |
| publisher | BioMed Central |
| record_format | Article |
| series | Genomics & Informatics |
| spelling | doaj-art-d8fb9bfdf4404df0898f8abc86882abf2025-02-02T03:13:31ZengBioMed CentralGenomics & Informatics2234-07422018-06-01162303510.5808/GI.2018.16.2.30509Comparison of the Genetic Alterations between Primary Colorectal Cancers and Their Corresponding Patient-Derived Xenograft TissuesSang Mi Yu0Seung-Hyun Jung1Yeun-Jun Chung2 Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea Integrated Research Center for Genome Polymorphism, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul 06591, KoreaPatient-derived xenograft (PDX) models are useful tools for tumor biology research and testing the efficacy of candidate anticancer drugs targeting the druggable mutations identified in tumor tissue. However, it is still unknown how much of the genetic alterations identified in primary tumors are consistently detected in tumor tissues in the PDX model. In this study, we analyzed the genetic alterations of three primary colorectal cancers (CRCs) and matched xenograft tissues in PDX models using a next-generation sequencing cancer panel. Of the 17 somatic mutations identified from the three CRCs, 14 (82.4%) were consistently identified in both primary and xenograft tumors. The other three mutations identified in the primary tumor were not detected in the xenograft tumor tissue. There was no newly identified mutation in the xenograft tumor tissues. In addition to the somatic mutations, the copy number alteration profiles were also largely consistent between the primary tumor and xenograft tissue. All of these data suggest that the PDX tumor model preserves the majority of the key mutations detected in the primary tumor site. This study provides evidence that the PDX model is useful for testing targeted therapies in the clinical field and research on precision medicine.http://genominfo.org/upload/pdf/gi-2018-16-2-30.pdfcolorectal cancermutationpatient-derived xenograft |
| spellingShingle | Sang Mi Yu Seung-Hyun Jung Yeun-Jun Chung Comparison of the Genetic Alterations between Primary Colorectal Cancers and Their Corresponding Patient-Derived Xenograft Tissues Genomics & Informatics colorectal cancer mutation patient-derived xenograft |
| title | Comparison of the Genetic Alterations between Primary Colorectal Cancers and Their Corresponding Patient-Derived Xenograft Tissues |
| title_full | Comparison of the Genetic Alterations between Primary Colorectal Cancers and Their Corresponding Patient-Derived Xenograft Tissues |
| title_fullStr | Comparison of the Genetic Alterations between Primary Colorectal Cancers and Their Corresponding Patient-Derived Xenograft Tissues |
| title_full_unstemmed | Comparison of the Genetic Alterations between Primary Colorectal Cancers and Their Corresponding Patient-Derived Xenograft Tissues |
| title_short | Comparison of the Genetic Alterations between Primary Colorectal Cancers and Their Corresponding Patient-Derived Xenograft Tissues |
| title_sort | comparison of the genetic alterations between primary colorectal cancers and their corresponding patient derived xenograft tissues |
| topic | colorectal cancer mutation patient-derived xenograft |
| url | http://genominfo.org/upload/pdf/gi-2018-16-2-30.pdf |
| work_keys_str_mv | AT sangmiyu comparisonofthegeneticalterationsbetweenprimarycolorectalcancersandtheircorrespondingpatientderivedxenografttissues AT seunghyunjung comparisonofthegeneticalterationsbetweenprimarycolorectalcancersandtheircorrespondingpatientderivedxenografttissues AT yeunjunchung comparisonofthegeneticalterationsbetweenprimarycolorectalcancersandtheircorrespondingpatientderivedxenografttissues |